{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T04:01:03Z","timestamp":1746936063590,"version":"3.40.5"},"reference-count":40,"publisher":"Japan Endocrine Society","issue":"5","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26460653"],"award-info":[{"award-number":["26460653"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002951","name":"Dokkyo Medical University","doi-asserted-by":"publisher","award":["00002269"],"award-info":[{"award-number":["00002269"]}],"id":[{"id":"10.13039\/501100002951","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0557","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T22:11:43Z","timestamp":1739916703000},"page":"535-543","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the potential of high-mobility group AT-hook 2 immunohistochemical staining as a prognostic marker of metastatic recurrence in follicular thyroid cancer: a retrospective cohort study"],"prefix":"10.1507","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4780-426X","authenticated-orcid":false,"given":"Yuka","family":"Ito","sequence":"first","affiliation":[{"name":"Department of Genetic Diagnosis and Laboratory Medicine, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Sakumoto","sequence":"additional","affiliation":[{"name":"Department of Genetic Diagnosis and Laboratory Medicine, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Hirabayashi","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Haruna","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Konno","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsuo","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2804-4588","authenticated-orcid":false,"given":"Kazuyuki","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6865-5159","authenticated-orcid":false,"given":"Yasuo","family":"Haruyama","sequence":"additional","affiliation":[{"name":"Department of Public Health, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8896-6501","authenticated-orcid":false,"given":"Toshimi","family":"Sairenchi","sequence":"additional","affiliation":[{"name":"Medical Science of Nursing, Dokkyo Medical University School of Nursing, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1786-0077","authenticated-orcid":false,"given":"Eijun","family":"Nishihara","sequence":"additional","affiliation":[{"name":"Kuma Hospital, Hyogo 650-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Fukata","sequence":"additional","affiliation":[{"name":"Kuma Hospital, Hyogo 650-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hishinuma","sequence":"additional","affiliation":[{"name":"Hishinuma Clinic, Kanagawa 239-0841, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2413-2564","authenticated-orcid":false,"given":"Takahiko","family":"Kogai","sequence":"additional","affiliation":[{"name":"Department of Genetic Diagnosis and Laboratory Medicine, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Frost L, Baez MA, Harrilal C, Garabedian A, Fernandez-Lima F, et al. (2015) The dimerization state of the Mammalian High Mobility Group Protein AT-Hook 2 (HMGA2). PLoS One 10: e0130478.","DOI":"10.1371\/journal.pone.0130478"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Mansoori B, Mohammadi A, Ditzel HJ, Duijf PHG, Khaze V, et al. (2021) HMGA2 as a critical regulator in cancer development. Genes (Basel) 12: 269.","DOI":"10.3390\/genes12020269"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420\u20131428.","DOI":"10.1172\/JCI39104"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Fusco A, Fedele M (2007) Roles of HMGA proteins in cancer. Nat Rev Cancer 7: 899\u2013910.","DOI":"10.1038\/nrc2271"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Morishita A, Zaidi MR, Mitoro A, Sankarasharma D, Szabolcs M, et al. (2013) HMGA2 is a driver of tumor metastasis. Cancer Res 73: 4289\u20134299.","DOI":"10.1158\/0008-5472.CAN-12-3848"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Takahashi T, Kawaji H, Murakawa Y, Hayashizaki Y, Murakami T, et al. (2021) Significance of HMGA2 expression as independent poor prognostic marker in perihilar and distal cholangiocarcinoma resected with curative intent. Eur J Surg Oncol 47: 394\u2013400.","DOI":"10.1016\/j.ejso.2020.08.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, et al. (2022) Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol 33: 27\u201363.","DOI":"10.1007\/s12022-022-09707-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Passler C, Scheuba C, Prager G, Kaczirek K, Kaserer K, et al. (2004) Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer 11: 131\u2013139.","DOI":"10.1677\/erc.0.0110131"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Su DH, Chang TC, Chang SH (2019) Prognostic factors on outcomes of follicular thyroid cancer. J Formos Med Assoc 118: 1144\u20131153.","DOI":"10.1016\/j.jfma.2018.11.010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Yamazaki H, Sugino K, Katoh R, Matsuzu K, Masaki C, et al. (2021) Outcomes for minimally invasive follicular thyroid carcinoma in relation to the change in age stratification in the AJCC 8th edition. Ann Surg Oncol 28: 3576\u20133583.","DOI":"10.1245\/s10434-020-09397-3"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11 Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, et al. (2011) Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid 21: 751\u2013757.","DOI":"10.1089\/thy.2010.0353"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12 Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, et al. (2012) Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma. Thyroid 22: 798\u2013804.","DOI":"10.1089\/thy.2012.0051"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Stenson G, Nilsson IL, Mu N, Larsson C, Lundgren CI, et al. (2016) Minimally invasive follicular thyroid carcinomas: prognostic factors. Endocrine 53: 505\u2013511.","DOI":"10.1007\/s12020-016-0876-y"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Zidan J, Kassem S, Kuten A (2000) Follicular carcinoma of the thyroid gland: prognostic factors, treatment, and survival. Am J Clin Oncol 23: 1\u20135.","DOI":"10.1097\/00000421-200002000-00001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Ito Y, Miyauchi A, Hirokawa M, Yamamoto M, Oda H, et al. (2018) Prognostic value of the 8th edition of the tumor-node-metastasis classification for patients with papillary thyroid carcinoma: a single-institution study at a high-volume center in Japan. Endocr J 65: 707\u2013716.","DOI":"10.1507\/endocrj.EJ18-0019"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Ito Y, Hirokawa M, Higashiyama T, Takamura Y, Miya A, et al. (2007) Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination. World J Surg 31: 1417\u20131424.","DOI":"10.1007\/s00268-007-9095-2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Ito Y, Hirokawa M, Masuoka H, Yabuta T, Kihara M, et al. (2013) Prognostic factors of minimally invasive follicular thyroid carcinoma: extensive vascular invasion significantly affects patient prognosis. Endocr J 60: 637\u2013642.","DOI":"10.1507\/endocrj.EJ12-0419"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Ito Y, Miyauchi A, Tomoda C, Hirokawa M, Kobayashi K, et al. (2014) Prognostic significance of patient age in minimally and widely invasive follicular thyroid carcinoma: investigation of three age groups. Endocr J 61: 265\u2013271.","DOI":"10.1507\/endocrj.EJ13-0512"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 O\u2019Neill CJ, Vaughan L, Learoyd DL, Sidhu SB, Delbridge LW, et al. (2011) Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol 37: 181\u2013185.","DOI":"10.1016\/j.ejso.2010.11.005"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Podda M, Saba A, Porru F, Reccia I, Pisanu A (2015) Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors. World J Surg Oncol 13: 193.","DOI":"10.1186\/s12957-015-0612-8"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Asari R, Koperek O, Scheuba C, Riss P, Kaserer K, et al. (2009) Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Ann Surg 249: 1023\u20131031.","DOI":"10.1097\/SLA.0b013e3181a77b7b"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Ito Y, Hirokawa M, Masuoka H, Yabuta T, Fukushima M, et al. (2013) Distant metastasis at diagnosis and large tumor size are significant prognostic factors of widely invasive follicular thyroid carcinoma. Endocr J 60: 829\u2013833.","DOI":"10.1507\/endocrj.EJ12-0454"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Lappinga PJ, Kip NS, Jin L, Lloyd RV, Henry MR, et al. (2010) HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules. Cancer Cytopathol 118: 287\u2013297.","DOI":"10.1002\/cncy.20095"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Kim BH, Kim SJ, Kim M, Lee SW, Jeong SY, et al. (2018) Diagnostic performance of HMGA2 gene expression for differentiation of malignant thyroid nodules: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 89: 856\u2013862.","DOI":"10.1111\/cen.13853"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Rodrigues R, Roque L, Espadinha C, Pinto A, Domingues R, et al. (2007) Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas. Oncol Rep 18: 917\u2013926.","DOI":"10.3892\/or.18.4.917"},{"key":"26","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1186\/s12885-019-6154-7","volume":"19","author":"SE Titov","year":"2019","unstructured":"26 Titov SE, Ivanov MK, Demenkov PS, Katanyan GA, Kozorezova ES, et al. (2019) Combined quantitation of HMGA2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears. BMC Cancer 19: 1010.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Chiappetta G, Ferraro A, Vuttariello E, Monaco M, Galdiero F, et al. (2008) HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias. Eur J Cancer 44: 1015\u20131021.","DOI":"10.1016\/j.ejca.2008.02.039"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28 Mayr C, Hemann MT, Bartel DP (2007) Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315: 1576\u20131579.","DOI":"10.1126\/science.1137999"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Vasko V, Espinosa AV, Scouten W, He H, Auer H, et al. (2007) Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci U S A 104: 2803\u20132808.","DOI":"10.1073\/pnas.0610733104"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Lloyd RV, Buehler D, Khanafshar E (2011) Papillary thyroid carcinoma variants. Head Neck Pathol 5: 51\u201356.","DOI":"10.1007\/s12105-010-0236-9"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Qiu K, Xie Q, Jiang S, Lin T (2020) miR-98-5p promotes apoptosis and inhibits migration and cell growth in papillary thyroid carcinoma through Bax\/Caspase-3 by HMGA2. J Clin Lab Anal 34: e23044.","DOI":"10.1002\/jcla.23044"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Rice SJ, Lai SC, Wood LW, Helsley KR, Runkle EA, et al. (2013) MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1 (TTF-1\/NKX2-1). J Biol Chem 288: 16348\u201316360.","DOI":"10.1074\/jbc.M113.474643"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Ding C, Shi T, Wu G, Man J, Han H, et al. (2022) The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2. Bioengineered 13: 6629\u20136640.","DOI":"10.1080\/21655979.2022.2044277"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Jang MH, Jung KC, Min HS (2015) The diagnostic usefulness of HMGA2, survivin, CEACAM6, and SFN\/14-3-3 \u03b4 in follicular thyroid carcinoma. J Pathol Transl Med 49: 112\u2013117.","DOI":"10.4132\/jptm.2015.01.31"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Li H, Zhao L, Zhang Z, Zhang H, Ding C, et al. (2017) Roles of microRNA let-7b in papillary thyroid carcinoma by regulating HMGA2. Tumour Biol 39: 1010428317719274.","DOI":"10.1177\/1010428317719274"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Prasad NB, Kowalski J, Tsai HL, Talbot K, Somervell H, et al. (2012) Three-gene molecular diagnostic model for thyroid cancer. Thyroid 22: 275\u2013284.","DOI":"10.1089\/thy.2011.0169"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Hirokawa M, Carney JA, Goellner JR, DeLellis RA, Heffess CS, et al. (2002) Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol 26: 1508\u20131514.","DOI":"10.1097\/00000478-200211000-00014"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Lo CY, Chan WF, Lam KY, Wan KY (2005) Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg 242: 708\u2013715.","DOI":"10.1097\/01.sla.0000186421.30982.d2"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Jin L, Lloyd RV, Henry MR, Erickson LA, Sebo TJ, et al. (2015) The diagnostic utility of combination of HMGA2 and IMP3 qRT-PCR testing in thyroid neoplasms. Appl Immunohistochem Mol Morphol 23: 36\u201343.","DOI":"10.1097\/PAI.0000000000000031"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Belge G, Meyer A, Klemke M, Burchardt K, Stern C, et al. (2008) Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias. Genes Chromosomes Cancer 47: 56\u201363.","DOI":"10.1002\/gcc.20505"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/5\/72_EJ24-0557\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T03:32:09Z","timestamp":1746847929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/5\/72_EJ24-0557\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0557","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"type":"print","value":"0918-8959"},{"type":"electronic","value":"1348-4540"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0557"}}